Design, synthesis, and structural activity relationship of antimicrobial peptides against multi-drug resistant organisms
Keywords:
antimicrobial, peptide, multi-drug, resistant, synthesisAbstract
Antimicrobial peptides (AMPs) are a family of tiny peptides found throughout nature that play a vital role in various organisms' innate immune systems. Antimicrobial peptides and proteins (AMPs) are a varied family of naturally occurring chemicals produced by all multicellular organisms as a first line of defense. The rising prevalence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) diseases is the most evident cause for concern. Traditional antimicrobial drugs work by targeting certain metabolic pathways or microbiological structures to kill or hinder bacterial growth. The development of new lead structures to combat multidrug-resistant bacteria is critical, and cationic antimicrobial peptides (AMPs) have the ability to do so. Based on the SPOT synthesis, we present an outline of a strategy for screening peptides for antimicrobial activity. Multidrug-resistant bacteria have grown fast in recent decades, leading to a rise in nosocomial infections and in-hospital mortality, as well as posing a threat to world health. We can say that he discovery of antibiotics signaled the start of a golden period in human medicine.
Downloads
References
Bei YH, Pan LL, Zhou QL, Zhao CM, Xie Y, Wu CF, Meng XM, Gu HY, Xu JH, Zhou L, Sluijter JPG, Das S, Agerberth B, Sun J, Xiao JJ. 2019. Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury. BMC Medicine, 17(1): 42.
López, Claudia. (2019). Design, synthesis, characterization and in vitro evaluation of antimicrobial peptides against pathogenic bacteria resistant to antibiotics. Revista de la Academia Colombiana de Ciencias Exactas Físicas y Naturales. 43. 614-627. 10.18257/raccefyn.864.
Moreno-Morales, Javier & Kalafatovic, Daniela & Ballesté-Delpierre, Clara & Giralt, Ernest & Vila, Jordi. (2018). Antimicrobial activity evaluation of newly designed antimicrobial peptides against multidrug-resistant bacteria.
David, Akinwale & Park, Shang Eun & Parang, Keykavous & Tiwari, Rakesh. (2018). Antibiotics-Peptide Conjugates Against Multidrug-Resistant Bacterial Pathogens. Current Topics in Medicinal Chemistry. 19. 10.2174/1568026619666181129141524.
Ayukekbong JA, Ntemgwa M, Atabe AN. 2017. The threat of antimicrobial resistance in developing countries: causes and control strategies. Antimicrobial Resistance & Infection Control, 6(1): 47.
Bechinger B, Gorr SU. 2017. Antimicrobial peptides: mechanisms of action and resistance. Journal of Dental Research, 96(3): 254–260.
Brunetti J, Falciani C, Roscia G, Pollini S, Bindi S, Scali S, Arrieta UC, Gómez-Vallejo V, Quercini L, Ibba E, Prato M, Rossolini GM, Llop J, Bracci L, Pini A. 2016a. In vitro and in vivo efficacy, toxicity, bio-distribution and resistance selection of a novel antibacterial drug candidate. Scientific Reports, 6: 26077–26077.
Cantisani M, Finamore E, Mignogna E, Falanga A, Nicoletti GF, Pedone C, Morelli G, Leone M, Galdiero M, Galdiero S. 2014. Structural insights into and activity analysis of the antimicrobial peptide myxinidin. Antimicrobial Agents and Chemotherapy, 58(9): 5280–5290.
Hilpert, Kai. (2011). Identifying Novel Antimicrobial Peptides with Therapeutic Potential Against Multidrug-Resistant Bacteria by Using the SPOT Synthesis. Mini-Reviews in Organic Chemistry. 8. 157-163. 10.2174/157019311795177781.
Davies J, Davies D. 2010. Origins and evolution of antibiotic resistance. Microbiology and Molecular Biology Reviews, 74(3): 417–433.
Brown SE, Howard A, Kasprzak AB, Gordon KH, East PD. 2009. A peptidomics study reveals the impressive antimicrobial peptide arsenal of the wax moth Galleria mellonella. Insect Biochemistry and Molecular Biology, 39(11): 792–800.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
![Creative Commons License](http://i.creativecommons.org/l/by-nc-nd/4.0/88x31.png)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.